Clinical observation on the effect of Lingze tablet in the treatment of BPH patients in community hospitals in the real world
- Conditions
- Benign prostatic hyperplasia
- Registration Number
- ITMCTR2000003376
- Lead Sponsor
- Dongzhimen Hospital Beijing University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- Not specified
1. Patients who meet the diagnostic criteria of BPH;
2. Male patients aged 50-80 years;
3. Patients who voluntarily sign informed consent.
1. Patients with BPH symptoms (such as diuretics, antihistamines or tricyclic antidepressants) were treated with other drugs with known efficacy within 4 weeks;
2. Patients with other previous urinary system diseases (prostatitis, urinary incontinence, urethral stricture or prostate cancer), or previous lower urinary tract surgery;
3. Patients with serious cardiovascular and cerebrovascular diseases, liver and kidney dysfunction and other serious primary diseases;
4. Allergic constitution and patients with severe drug allergy history;
5. Patients with mental diseases;
6. Patients who participated in other clinical studies 6 months before the study.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method IPSS;B-mode ultrasonography;PSA;QOL;Urinary flow rate;
- Secondary Outcome Measures
Name Time Method